Use of fab fragments of digoxin-specific antibodies in the therapy of massive digoxin poisoning. 1985

J Leikin, and S Vogel, and J Graff, and R Goldman-Leikin, and V P Butler, and E Haber, and T W Smith

A case of massive digoxin ingestion with multiple arrhythmias, consisting of high grade A-V block and ventricular ectopy not responsive to lidocaine, is described. The arrhythmias ceased following administration of digoxin-specific Fab fragments. The patient improved and was transferred to the psychiatric unit.

UI MeSH Term Description Entries
D007140 Immunoglobulin Fab Fragments Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fab Fragment,Fab Fragments,Ig Fab Fragments,Immunoglobulins, Fab Fragment,Fab Immunoglobulin Fragments,Immunoglobulin Fab Fragment,Immunoglobulins, Fab,Fab Fragment Immunoglobulins,Fab Fragment, Immunoglobulin,Fab Fragments, Immunoglobulin,Fragment Immunoglobulins, Fab,Fragment, Fab,Immunoglobulin Fragments, Fab
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011041 Poisoning A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent. Poisonings
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

J Leikin, and S Vogel, and J Graff, and R Goldman-Leikin, and V P Butler, and E Haber, and T W Smith
September 1982, Pediatrics,
J Leikin, and S Vogel, and J Graff, and R Goldman-Leikin, and V P Butler, and E Haber, and T W Smith
April 1986, The Ulster medical journal,
J Leikin, and S Vogel, and J Graff, and R Goldman-Leikin, and V P Butler, and E Haber, and T W Smith
November 2008, Critical care medicine,
J Leikin, and S Vogel, and J Graff, and R Goldman-Leikin, and V P Butler, and E Haber, and T W Smith
October 1982, La Nouvelle presse medicale,
J Leikin, and S Vogel, and J Graff, and R Goldman-Leikin, and V P Butler, and E Haber, and T W Smith
July 1988, Annals of emergency medicine,
J Leikin, and S Vogel, and J Graff, and R Goldman-Leikin, and V P Butler, and E Haber, and T W Smith
November 1996, Chest,
J Leikin, and S Vogel, and J Graff, and R Goldman-Leikin, and V P Butler, and E Haber, and T W Smith
December 1993, Annals of emergency medicine,
J Leikin, and S Vogel, and J Graff, and R Goldman-Leikin, and V P Butler, and E Haber, and T W Smith
April 1976, The New England journal of medicine,
J Leikin, and S Vogel, and J Graff, and R Goldman-Leikin, and V P Butler, and E Haber, and T W Smith
October 1989, Journal of clinical pharmacology,
J Leikin, and S Vogel, and J Graff, and R Goldman-Leikin, and V P Butler, and E Haber, and T W Smith
January 1985, Pediatric cardiology,
Copied contents to your clipboard!